参考文献/References:
[1]沈丹洋,张曼晖.农村男性人群体质指数与心血管疾病死亡关系的前瞻性随访研究[J].中华流行病学杂志,2020,41(12):2072-2079.[2]杨春澜,孟祥武,郑龙,等.大黄素通过TLR4/NF-κB信号通路减轻缺糖/缺氧对小胶质细胞的损伤[J].中国病理生理杂志,2019,35(12):2285-2289.[3]Zhai C,Qian G,Wu H,et al.Knockdown of circ_0060745 alleviates acute myocardial infarction by suppressing NF-κB activation[J].J Cell Mol Med,2020,24(21):12401-12410.[4]Cui Y,Chen LJ,Huang T,et al.The pharmacology, toxicology andtherapeutic potential of anthraquinone derivative emodin[J].Chin J Nat Med,2020,18(6):425-435.[5]Zhang X,Qin Q,Dai H,et al.Emodin protects H9c2 cells from hypoxia-induced injury by up-regulating miR-138 expression[J].Braz J Med Biol Res,2019,52(3):179-194.[6]Niu N,Xu S,Xu Y,et al.Targeting Mechanosensitive Transcription Factors in Atherosclerosis[J].Trends Pharmacol Sci,2019,40(4):253-266.[7]Badimon L,Peｎa E,Arderiu G,et al.C-Reactive Protein in Atherothrombosis and Angiogenesis[J].Front Immunol,2018,9:430.[8]Pang X,Liu J,Li Y,et al.Emodin Inhibits Homocysteine-Induced C-Reactive Protein Generation in Vascular Smooth Muscle Cells by Regulating PPARγ Expression and ROS-ERK1/2/p38 Signal Pathway[J].PLoS One,2015,10(7):131-141.[9]Lin W,Zhong M,Liang S,et al.Emodininhibits migration and invasion of MHCC-97H human hepatocellular carcinomacells[J].Exp Ther Med.2016,12(5):3369-3374.[10]Wang Y,Wang W,Xu H,et al.Non-Lethal Sonodynamic Therapy Inhibits Atherosclerotic Plaque Progression in ApoE-/- Mice and Attenuates ox-LDL-mediated Macrophage Impairment by Inducing Heme Oxygenase-1[J].Cell Physiol Biochem,2017,41(6):2432-2446.[11]Qian J,Gao Q.Sonodynamic Therapy Mediated by Emodin Induces the Oxidationof Microtubules to Facilitate the Sonodynamic Effect[J].Ultrasound Med Biol,2018,44(4):853-860.[12]Xiao D,Hu Y,Fu Y,et al.Emodin improves glucose metabolism by targeting microRNA-20b in insulin-resistant skeletal muscle[J].Phytomedicine,2019,59:152758.[13]Wu Z,Chen Q,Ke D,et al.Emodin protects against diabetic cardiomyopathy by regulating the AKT/GSK-3β signaling pathway in the rat model[J].Molecules,2014,19(9):14782-14793.[14]Liu Z,Ma N,Zhong Y.Antiviral effect of emodin from Rheum palmatum against coxsakievirus B5 and human respiratory syncytial virus in vitro[J].J Huazhong Univ Sci Technolog Med Sci,2015,35(6):916-922.[15]Zhang HM,Wang F,Qiu Y,et al.Emodin inhibits coxsackievirus B3 replication via multiple signalling cascades leading to suppression of translation[J].Biochem J,2016,473(4):473-485.[16]Voelkl J,Lang F,Eckardt KU,et al.Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia[J].Cell Mol Life Sci,2019,76(11):2077-2091[17]Masaki N,Ido Y,Yamada T,et al.Endothelial Insulin Resistance of Freshly Isolated Arterial Endothelial Cells from Radial Sheaths in Patients With Suspected Coronary Artery Disease[J].J Am Heart Assoc,2019,8:e010816.[18]Shou X,Zhou R,Zhu L,et al.Emodin, A Chinese Herbal Medicine, Inhibits Reoxygenation-Induced Injury in Cultured Human Aortic Endothelial Cells by Regulating the Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) and Endothelial Nitric Oxide Synthase (eNOS) Signaling Pathway[J].Med Sci Monit.,2018,24:643-651.[19]Wang J,Zhang Y,Zhu Q,et al.Emodin protects mice against radiation-induced mortality and intestinal injury via inhibition of apoptosis and modulation of p53[J].Environ Toxicol Pharmacol,2016,46:311-318.[20]Gao Y,Zhang J,Li G,et al.Protection of vascular endothelial cells from high glucose-induced cytotoxicity by emodin[J].Biochem Pharmacol,2015,94(1):39-45.[21]Frismantiene A,Philippova M,Erne P,et al.Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity[J].Cell Signal,2018,52(2):48-64.[22]Lim KM,Kwon JH,Kim K,et al.Emodin inhibits tonic tension through suppressing PKCδ-mediated inhibition of myosin phosphatase in rat isolated thoracic aorta[J].Br J Pharmacol,2014,171(18):4300-4310.[23]Huang X,Liu Z,Shen L,et al.Augmentation of miR-202 in varicose veins modulates phenotypic transition of vascular smooth muscle cells by targeting proliferator-activated receptor-γ coactivator-1α[J].J Cell Biochem,2019,120(6):10031-10042.[24]Xu K,Al-Ani MK,Wang C,et al.Emodin as a selective proliferative inhibitor of vascular smooth muscle cells versus endothelial cells suppress arterial intima formation[J].Life Sci,2018,207:9-14.[25]Lu R,Tang F,Zhang Y,et al.Comparison of Drug-Eluting and Bare Metal Stents in Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis[J].J Am Heart Assoc,2016,5(11):e003990.[26]Zhang HM,Wang F,Qiu Y,et al.Emodin inhibits coxsackievirus B3 replication via multiple signalling cascades leading to suppression of translation[J].Biochem J,2016,473:473-85.[27]邬瑾.心血管病患者药物涂层支架载入药物的筛选与应用[J].中国组织工程研究,2016,20(38):5770-5776.
相似文献/References:
[1]郭俊林,张 立.基质金属蛋白酶-2与冠状动脉粥样硬化性疾病的研究进展[J].医学信息,2018,31(04):27.[doi:10.3969/j.issn.1006-1959.2018.04.010]
GUO Jun-lin,ZHANG Li.Progress of the Researchon Matrix Metalloproteinase-2 and Coronary Atherosclerotic Disease[J].Medical Information,2018,31(11):27.[doi:10.3969/j.issn.1006-1959.2018.04.010]
[2]王立民,刘有旺,王恩波,等.以大黄素为声敏剂介导声动力疗法对小鼠
动脉粥样硬化治疗作用的研究[J].医学信息,2018,31(06):58.[doi:10.3969/j.issn.1006-1959.2018.06.019]
WANG Li-min,LIU You-wang,WANG En-bo,et al.Study on the Effect of Emodin on the Treatment of Atherosclerosis in Mice[J].Medical Information,2018,31(11):58.[doi:10.3969/j.issn.1006-1959.2018.06.019]
[3]张 慧,黄艳群,王 妮,等.基于美国全国住院病人样本的心血管疾病研究进展[J].医学信息,2018,31(07):43.[doi:10.3969/j.issn.1006-1959.2018.06.015]
ZHANG Hui,HUANG Yan-qun,WANG Ni,et al.Research Progress of Cardiovascular Disease Based on National Inpatient Sample[J].Medical Information,2018,31(11):43.[doi:10.3969/j.issn.1006-1959.2018.06.015]
[4]平兰芝,黄小楼,胡天俊,等.CaMKⅡ在心血管疾病中的研究[J].医学信息,2022,35(10):59.[doi:10.3969/j.issn.1006-1959.2022.10.014]
PING Lan-zhi,HUANG Xiao-lou,HU Tian-jun,et al.Research on the Role of CaMKⅡ in Cardiovascular Diseases[J].Medical Information,2022,35(11):59.[doi:10.3969/j.issn.1006-1959.2022.10.014]
[5]李 晶,黄 波.抗血小板药物治疗心血管疾病的研究现状[J].医学信息,2022,35(10):83.[doi:10.3969/j.issn.1006-1959.2022.10.020]
LI Jing,HUANG Bo.Research Status of Antiplatelet Drugs in the Treatment of Cardiovascular Diseases[J].Medical Information,2022,35(11):83.[doi:10.3969/j.issn.1006-1959.2022.10.020]
[6]徐炜棉,郭金莲,王燕琴,等.铁代谢及铁蛋白与心血管疾病关系的现状分析[J].医学信息,2018,31(22):39.[doi:10.3969/j.issn.1006-1959.2018.22.012]
XU Wei-mian,GUO Jin-lian,WANG Yan-qin,et al.Analysis of the Relationship between Iron Metabolism and Ferritin and Cardiovascular Diseases[J].Medical Information,2018,31(11):39.[doi:10.3969/j.issn.1006-1959.2018.22.012]
[7]刘瑞芳,赵 华,史红娟,等.益生菌与2型糖尿病心血管疾病的研究进展[J].医学信息,2019,32(18):29.[doi:10.3969/j.issn.1006-1959.2019.18.010]
LIU Rui-fang,ZHAO Hua,SHI Hong-juan,et al.Advances in Research on Probiotics and Cardiovascular Diseases in Type 2 Diabetes[J].Medical Information,2019,32(11):29.[doi:10.3969/j.issn.1006-1959.2019.18.010]
[8]闫娜娜,李雪萍,李 亚,等.FGF23与心血管疾病的研究进展[J].医学信息,2019,32(19):43.[doi:10.3969/j.issn.1006-1959.2019.19.014]
YAN Na-na,LI Xue-ping,LI Ya,et al.Progress in Research on FGF23 and Cardiovascular Diseases[J].Medical Information,2019,32(11):43.[doi:10.3969/j.issn.1006-1959.2019.19.014]
[9]袁国铭,陈新利,袁国娜,等.心脏病健康知识系统构建与应用[J].医学信息,2019,32(22):8.[doi:10.3969/j.issn.1006-1959.2019.22.003]
YUAN Guo-ming,CHEN Xin-li,YUAN Guo-na,et al.The Construction and Application of Heart Health Knowledge System[J].Medical Information,2019,32(11):8.[doi:10.3969/j.issn.1006-1959.2019.22.003]
[10]杨 敏,汤云昭,倪长林.2型糖尿病患者心血管疾病的发病机制[J].医学信息,2020,33(06):56.[doi:10.3969/j.issn.1006-1959.2020.06.017]
YANG Min,TANG Yun-zhao,NI Chang-lin.The Pathogenesis of Cardiovascular Disease in Patients with Type 2 Diabetes[J].Medical Information,2020,33(11):56.[doi:10.3969/j.issn.1006-1959.2020.06.017]